Plastic Surgery in the Time of COVID-19

2020 ◽  
Author(s):  
David Chi ◽  
Austin D. Chen ◽  
Miguel I. Dorante ◽  
Bernard T. Lee ◽  
Justin M. Sacks
Keyword(s):  
Health Care Systems ◽  
Lessons Learned ◽  
Difficult Decision ◽  
Global Pandemic ◽  
Life Saving ◽  
The World ◽  
Future Challenges ◽  
Care Systems ◽  
To Come ◽  
Novel Coronavirus

Abstract Background The novel coronavirus disease 2019 (COVID-19) has swept the world in the last several months, causing massive disruption to existing social, economic, and health care systems. As with all medical fields, plastic and reconstructive surgery has been profoundly impacted across the entire spectrum of practice from academic medical centers to solo private practice. The decision to preserve vital life-saving equipment and cancel elective procedures to protect patients and medical staff has been extremely challenging on multiple levels. Frequent and inconsistent messaging disseminated by many voices on the national stage often conflicts and serves only to exacerbate an already difficult decision-making process. Methods A survey of relevant COVID-19 literature is presented, and bioethical principles are utilized to generate guidelines for plastic surgeons in patient care through this pandemic. Results A cohesive framework based upon core bioethical values is presented here to assist plastic surgeons in navigating this rapidly evolving global pandemic. Conclusion Plastic surgeons around the world have been affected by COVID-19 and will adapt to continue serving their patients. The lessons learned in this present pandemic will undoubtedly prove useful in future challenges to come.

Rapid Development and Deployment of Respiratory Evaluation Clinics in Response to the COVID-19 Pandemic to Keep Staff and Patients Safe

2021 ◽  
pp. 38-42
Author(s):  
Charles Haddad ◽  
Christopher Scuderi ◽  
Judelle Haddad-Lacle ◽  
Reetu Grewal ◽  
Jeffrey Jacqmein ◽  
...  
Keyword(s):  
Infectious Disease ◽  
Rapid Development ◽  
Lessons Learned ◽  
The Novel ◽  
Global Pandemic ◽  
Vulnerable Patients ◽  
The World ◽  
Novel Coronavirus ◽  
Geographical Locations ◽  
The U.S

The world as we knew it changed at the beginning of 2020 with the explosion of the global pandemic caused by SARS-CoV-2, a.k.a. COVID-19. As of January 10, 2021, the novel coronavirus has infected over 89 million people worldwide and killed over 1.9 million. In the U.S., there have been 22 million people infected and 373,000 deaths. It has never been more important to protect our vulnerable patients and staff from infectious disease, especially during the time they spend in our offices and clinics. It quickly became apparent that there was a need for a dedicated location where patients could be seen that were too ill to be evaluated via telemedicine, but not ill enough to be sent to the Emergency Department (ED). To fill this need, our primary care network developed the Respiratory Evaluation Clinic (REC) concept. These were two geographical locations where the outlying clinics could send potentially infectious patients to evaluate and test COVID-19. Some recommendations, adaptations, lessons learned and the REC clinics' expansions to other locations throughout our network are discussed.

scholarly journals Epidemiological Investigation Model of Novel Coronavirus Pneumonia Based on Data Mining Technology

2021 ◽  
Vol 292 ◽  
pp. 03026
Author(s):  
Kai Chen ◽  
Bing Yang ◽  
Miao Hao ◽  
Hong Yang ◽  
Meiyuan Qin ◽  
...  
Keyword(s):  
Data Mining ◽  
Health Care Systems ◽  
Epidemiological Investigation ◽  
Health Concerns ◽  
Care Systems ◽  
To Come ◽  
Using Data ◽  
Novel Coronavirus ◽  
Available Information ◽  
And Control

With its extraordinary rapidity of transmission, the COVID-19 pandemic demonstrates the vulnerability of a globalized and networked world. The first months of the pandemic were marked by a significant strain on health-care systems. Since the prospect of pandemics has elevated public health concerns, it is critical to revisit this issue. The primary goal of this essay is to employ data mining technologies and methodologies to do investigative analysis on publicly available information. In this article we shared ways and techniques to handle and control this pandemic in the best possible way using data mining techniques and models. Researchers and scientists will be able to use the results of our poll to come up with new approaches to combat the pandemic.

scholarly journals Preparedness and Lessons Learned from the Novel Coronavirus Disease

2020 ◽  
Vol 11 (2) ◽  
pp. 108-112 ◽  
Author(s):  
Sai Krishna Gudi ◽  
Komal Krishna Tiwari
Keyword(s):  
Public Health Emergency ◽  
Lessons Learned ◽  
The Novel ◽  
Global Consciousness ◽  
The Past ◽  
Global Pandemic ◽  
The World ◽  
Entire World ◽  
Short Span ◽  
Novel Coronavirus

In a short span, a novel coronavirus (SARS-CoV-2) has captured global consciousness by significantly affecting the day-to-day life of humans and emerged as a public health emergency. Undoubtedly, it indicates that lessons learnt from the past epidemics of coronaviruses such as the Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS), had not enough and thus left us ill-prepared to deal with the challenges that COVID-19 pandemic is currently posing. Currently, as a global pandemic, COVID-19 poses major challenges and thus forcing the entire world to lockdown. However, the disease has prepared humankind in facing such outbreaks at present as well as in the future. Besides, it has also taught numerous lessons that are worth considering and implementing to make the world a better reality.

scholarly journals Infection by the Novel Coronavirus (Covid-19) and Pregnancy: 2 Cases Reports at the University Teaching Hospital of Angre/Abidjan

2020 ◽  
pp. 1-3
Author(s):  
Adjoby Cassou Roland ◽  
◽  
Gbary-Lagaud Eleonore ◽  
Effoh Ndrin Denis ◽  
◽  
...  
Keyword(s):  
Health Care Systems ◽  
Current Data ◽  
University Teaching ◽  
University Hospital ◽  
World Health ◽  
The Novel ◽  
The World ◽  
Care Systems ◽  
Novel Coronavirus ◽  
Health Organization

The novel coronavirus (SARS-Cov-2) that appeared in December 2019 in China quickly spread to all countries around the world leading the World Health Organization (WHO) to declare a pandemic on 11 March 2020. This pandemic is particularly serious in that it severely undermines health care systems in all affected countries, including developing and resource-constrained countries, forcing them to adapt quickly. Current data on COVID-19 and pregnancy are limited. The first published Chinese data seem to show that the symptoms in pregnant women are substantially the same as those in the general population. Through the first 2 cases of COVID-19 observed during pregnancy at Angré University Hospital, the authors wanted to share their experience, under the conditions of a low-resources country.

scholarly journals Infection by the Novel Coronavirus (Covid-19) and Pregnancy: 2 Cases Reports at the University Teaching Hospital of Angre/Abidjan

2020 ◽  
pp. 1-3
Author(s):  
Adjoby Cassou Roland ◽  
◽  
Gbary-Lagaud Eleonore ◽  
Effoh Ndrin Denis ◽  
◽  
...  
Keyword(s):  
Health Care Systems ◽  
Current Data ◽  
University Teaching ◽  
University Hospital ◽  
World Health ◽  
The Novel ◽  
The World ◽  
Care Systems ◽  
Novel Coronavirus ◽  
Health Organization

The novel coronavirus (SARS-Cov-2) that appeared in December 2019 in China quickly spread to all countries around the world leading the World Health Organization (WHO) to declare a pandemic on 11 March 2020. This pandemic is particularly serious in that it severely undermines health care systems in all affected countries, including developing and resource-constrained countries, forcing them to adapt quickly. Current data on COVID-19 and pregnancy are limited. The first published Chinese data seem to show that the symptoms in pregnant women are substantially the same as those in the general population. Through the first 2 cases of COVID-19 observed during pregnancy at Angré University Hospital, the authors wanted to share their experience, under the conditions of a low-resources country

Synthetic and semi-synthetic drugs as promising therapeutic option for the treatment of COVID-19

2020 ◽  
Vol 20 ◽  
Author(s):  
Ekta Shirbhate ◽  
Preeti Patel ◽  
Vijay K Patel ◽  
Ravichandran Veerasamy ◽  
Prabodh C Sharma ◽  
...  
Keyword(s):  
Therapeutic Option ◽  
Antiviral Treatment ◽  
The Novel ◽  
Clinical Experiences ◽  
Synthetic Compounds ◽  
Synthetic Drugs ◽  
Global Pandemic ◽  
The World ◽  
Novel Coronavirus

: The novel coronavirus disease-19 (COVID-19), a global pandemic that emerged from Wuhan, China has today travelled all around the world, so far 216 countries or territories with 21,732,472 people infected and 770,866 deaths globally (as per WHO COVID-19 update dated August 18, 2020). Continuous efforts are being made to repurpose the existing drugs and develop vaccines for combating this infection. Despite, to date, no certified antiviral treatment or vaccine prevails. Although, few candidates have displayed their efficacy in in vitro studies and are being repurposed for COVID-19 treatment. This article summarizes synthetic and semi-synthetic compounds displaying potent activity in their clinical experiences or studies against COVID-19 and also focuses on mode of action of drugs being repositioned against COVID-19.

scholarly journals Current Understanding of Novel Coronavirus: Molecular Pathogenesis, Diagnosis, and Treatment Approaches

Immuno ◽  
2021 ◽  
Vol 1 (1) ◽  
pp. 30-66
Author(s):  
Niraj Kumar Jha ◽  
Madhan Jeyaraman ◽  
Mahesh Rachamalla ◽  
Shreesh Ojha ◽  
Kamal Dua ◽  
...  
Keyword(s):  
Paradigm Shift ◽  
Functional Outcomes ◽  
Cellular Therapy ◽  
Treatment Modalities ◽  
Unknown Etiology ◽  
Huge Number ◽  
The World ◽  
To Come ◽  
Novel Coronavirus ◽  
Nano Medicine

An outbreak of “Pneumonia of Unknown Etiology” occurred in Wuhan, China, in late December 2019. Later, the agent factor was identified and coined as SARS-CoV-2, and the disease was named coronavirus disease 2019 (COVID-19). In a shorter period, this newly emergent infection brought the world to a standstill. On 11 March 2020, the WHO declared COVID-19 as a pandemic. Researchers across the globe have joined their hands to investigate SARS-CoV-2 in terms of pathogenicity, transmissibility, and deduce therapeutics to subjugate this infection. The researchers and scholars practicing different arts of medicine are on an extensive quest to come up with safer ways to curb the pathological implications of this viral infection. A huge number of clinical trials are underway from the branch of allopathy and naturopathy. Besides, a paradigm shift on cellular therapy and nano-medicine protocols has to be optimized for better clinical and functional outcomes of COVID-19-affected individuals. This article unveils a comprehensive review of the pathogenesis mode of spread, and various treatment modalities to combat COVID-19 disease.

scholarly journals Progression and Trends in Virus from Influenza A to COVID-19: An Overview of Recent Studies

Viruses ◽  
2021 ◽  
Vol 13 (6) ◽  
pp. 1145
Author(s):  
Hakimeh Baghaei Daemi ◽  
Muhammad Fakhar-e-Alam Kulyar ◽  
Xinlin He ◽  
Chengfei Li ◽  
Morteza Karimpour ◽  
...  
Keyword(s):  
Influenza A ◽  
H1n1 Virus ◽  
World Health ◽  
H1n1 Pandemic ◽  
Global Pandemic ◽  
First Case ◽  
Influenza A H1n1 ◽  
The World ◽  
Novel Coronavirus ◽  
Health Organization

Influenza is a highly known contagious viral infection that has been responsible for the death of many people in history with pandemics. These pandemics have been occurring every 10 to 30 years in the last century. The most recent global pandemic prior to COVID-19 was the 2009 influenza A (H1N1) pandemic. A decade ago, the H1N1 virus caused 12,500 deaths in just 19 months globally. Now, again, the world has been challenged with another pandemic. Since December 2019, the first case of a novel coronavirus (COVID-19) infection was detected in Wuhan. This infection has risen rapidly throughout the world; even the World Health Organization (WHO) announced COVID-19 as a worldwide emergency to ensure human health and public safety. This review article aims to discuss important issues relating to COVID-19, including clinical, epidemiological, and pathological features of COVID-19 and recent progress in diagnosis and treatment approaches for the COVID-19 infection. We also highlight key similarities and differences between COVID-19 and influenza A to ensure the theoretical and practical details of COVID-19.

scholarly journals A Comprehensive Study of Artificial Intelligence and Machine Learning Approaches in Confronting the Coronavirus (COVID-19) Pandemic

2021 ◽  
pp. 002073142110174
Author(s):  
Md Mijanur Rahman ◽  
Fatema Khatun ◽  
Ashik Uzzaman ◽  
Sadia Islam Sami ◽  
Md Al-Amin Bhuiyan ◽  
...  
Keyword(s):  
Artificial Intelligence ◽  
Machine Learning ◽  
Health Care ◽  
Language Processing ◽  
Probabilistic Models ◽  
Health Care Systems ◽  
Learning Approaches ◽  
Care Systems ◽  
Novel Coronavirus ◽  
Comprehensive Study

The novel coronavirus disease (COVID-19) has spread over 219 countries of the globe as a pandemic, creating alarming impacts on health care, socioeconomic environments, and international relationships. The principal objective of the study is to provide the current technological aspects of artificial intelligence (AI) and other relevant technologies and their implications for confronting COVID-19 and preventing the pandemic’s dreadful effects. This article presents AI approaches that have significant contributions in the fields of health care, then highlights and categorizes their applications in confronting COVID-19, such as detection and diagnosis, data analysis and treatment procedures, research and drug development, social control and services, and the prediction of outbreaks. The study addresses the link between the technologies and the epidemics as well as the potential impacts of technology in health care with the introduction of machine learning and natural language processing tools. It is expected that this comprehensive study will support researchers in modeling health care systems and drive further studies in advanced technologies. Finally, we propose future directions in research and conclude that persuasive AI strategies, probabilistic models, and supervised learning are required to tackle future pandemic challenges.

scholarly journals Contributory role of SARS-CoV-2 genomic variations and life expectancy in COVID-19 transmission and low fatality rate in Africa

2020 ◽  
Vol 21 (1) ◽  
Author(s):  
Olabode E. Omotoso
Keyword(s):  
Mutational Analysis ◽  
Health Care Systems ◽  
Selective Advantage ◽  
African Population ◽  
Young Generation ◽  
Regulatory Policies ◽  
Recurrent Mutations ◽  
Mutational Hotspots ◽  
Care Systems ◽  
Novel Coronavirus

Abstract Background The novel coronavirus disease (COVID-19) has claimed lots of lives, posing a dire threat to global health. It was predicted that the coronavirus outbreak in the African population would be very lethal and result to economic devastation owing to the prevalence of immune-compromised population, poverty, low lifespan, fragile health care systems, poor economy, and lifestyle factors. Accumulation of mutations gives virus selective advantage for host invasion and adaptation, higher transmissibility of more virulent strains, and drug resistance. The present study determined the severe acute respiratory syndrome-2 (SARS-CoV-2) genomic variability and the contributory factors to the low COVID-19 fatality in Africa. To assess the SARS-CoV-2 mutational landscape, 924 viral sequences from the Africa region with their sociobiological characteristics mined from the Global Initiative on Sharing All Influenza Data (GISAID) database were analyzed. Results Mutational analysis of the SARS-CoV-2 sequences revealed highly recurrent mutations in the SARS-CoV-2 spike glycoprotein D614G (97.2%), concurrent R203K, and G204R (65.2%) in the nucleocapsid phosphoprotein, and P4715L (97.2%) in the RNA-dependent RNA polymerase flagging these regions as SARS-CoV-2 mutational hotspots in the African population. COVID-19 is more severe in older people (> 65 years); Africa has a low percentage of people within this age group (4.36%). The average age of the infected patients observed in this study is 46 years with only 47 infected patients (5.1%) above 65 years in Africa in comparison to 13.12% in countries in other continents with the highest prevalence of COVID-19. Conclusions Africa’s young generation, the late incidence of the disease, and adherence to public health guidelines are important indicators that may have contributed to the observed low COVID-19 deaths in Africa. However, with the easing of lockdown and regulatory policies, daily increasing incidence in most countries, and low testing and sequencing rate, the epidemiology and the true impact of the pandemic in Africa remain to be unraveled.

Sign in / Sign up

Export Citation Format

Share Document